Moderna’s COVID-19 vaccine is the third to be approved in the U.K., behind a vaccine developed by Pfzier and BioNTech and a second developed by AstraZeneca and Oxford University.
The vaccine developed by Moderna is delivered in two doses 28 days apart and is approved for people 18 years and older.
The United Kingdom is currently battling an overwhelming surge of a new, more contagious strain of COVID-19. England is under a lockdown in an effort to curb the spread, and people are not permitted to leave their homes other than for essential errands.
Health officials report more than 2.89 million cases of the virus in the U.K. and more than 78,630 people have died.
Moderna’s COVID-19 vaccine has been approved by the United Kingdom’s medicines regulator, making it the third vaccine authorized in the U.K on Friday
The U.K. government secured an additional 10 million doses of the vaccine for a total of 17 million doses with supply beginning in spring, Moderna said.